Natixis Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19.8M | Buy |
227,091
+76,147
| +50% | +$6.65M | 0.03% | 479 |
|
2025
Q1 | $10.3M | Sell |
150,944
-42,588
| -22% | -$2.91M | 0.02% | 627 |
|
2024
Q4 | $15.1M | Buy |
193,532
+158,124
| +447% | +$12.3M | 0.03% | 534 |
|
2024
Q3 | $2.37M | Sell |
35,408
-1,056,986
| -97% | -$70.8M | ﹤0.01% | 1040 |
|
2024
Q2 | $124M | Sell |
1,092,394
-63,606
| -6% | -$7.21M | 0.27% | 81 |
|
2024
Q1 | $160M | Buy |
1,156,000
+26,430
| +2% | +$3.67M | 0.37% | 54 |
|
2023
Q4 | $140M | Buy |
1,129,570
+661,584
| +141% | +$82.1M | 0.37% | 53 |
|
2023
Q3 | $43.7M | Buy |
467,986
+413,407
| +757% | +$38.6M | 0.13% | 172 |
|
2023
Q2 | $7.01M | Buy |
54,579
+2,295
| +4% | +$295K | 0.02% | 619 |
|
2023
Q1 | $6.07M | Buy |
52,284
+11,683
| +29% | +$1.36M | 0.02% | 637 |
|
2022
Q4 | $4.6M | Buy |
40,601
+6,736
| +20% | +$763K | 0.02% | 703 |
|
2022
Q3 | $2.73M | Sell |
33,865
-3,054
| -8% | -$246K | 0.01% | 811 |
|
2022
Q2 | $2.75M | Buy |
+36,919
| New | +$2.75M | 0.01% | 811 |
|
2014
Q3 | – | Sell |
-27,508
| Closed | -$273K | – | 1060 |
|
2014
Q2 | $273K | Buy |
27,508
+6,240
| +29% | +$61.9K | ﹤0.01% | 1184 |
|
2014
Q1 | $220K | Buy |
+21,268
| New | +$220K | ﹤0.01% | 1173 |
|